EMIKO NARO: Open Payments
NPI 1669967998 · SKANEATELES, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 42 payments from 17 companies in 2025. Trend: 2023 $428 · 2024 $683 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $228 |
| AstraZeneca Pharmaceuticals LP | 4 | $151 |
| ABBVIE INC. | 5 | $88 |
| Novo Nordisk Inc | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Corium, LLC | 3 | $29 |
Products named: REZDIFFRA, FARXIGA, Kerendia, Rybelsus, MOUNJARO, DALVANCE, TZIELD, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
